Quantcast

Subscribe

Enter your email:

Delivered by FeedBurner

Posts Tagged ‘James Mitarotonda Barington Capital’

Jeffrey Ubben, James Mitarotonda, Brevan Howard

Ubben’s Latest Move (Marketwatch)
Valeant Pharmaceuticals International’s $5.7 billion bid for drug maker Cephalon Inc. is the latest in an acquisition spree backed by Jeff Ubben’s activist hedge fund firm ValueAct Capital Management. ValueAct’s largest holding is Valeant, a position the firm has held for a few years. The position is over 20% of ValueAct’s equity portfolio, which is worth over $4 billion. That makes Ubben’s firm the third-largest Valeant shareholder, behind Fidelity and value investing firm Ruane, Cuniff & Goldfarb, according to FactSet data. ValueAct partner G. Mason Morfit joined Valeant’s board in 2007 and the chief executive was replaced in 2008 with a former McKinsey & Co. partner, J. Michael Pearson. (more…)

Comments | Share

Insider Trading Alert: 3 Stocks Insiders Are Buying Like Crazy

For the past seven weeks, Insider Monkey has been publishing articles about the stocks insiders were buying like crazy. The stocks we listed in the previous 6 articles have performed spectacularly compared to the S&P 500. Insiders know more about their companies than do most investors. This holds especially true in smaller companies, which are either followed by only a few analysts or none at all. Academic studies conducted during the past 40 years confirm that stocks bought by several insiders outperform the market by about 7 percentage points per year in those studies.

Last week, we brought 3 more companies insiders are buying to your attention. Here are their performance numbers since we highlighted them:

1. Trailer Bridge Inc (TRBR): Trailer Bridge was also in our list during the previous week, returning 19% vs. 1.7% for the S&P 500 index. Last week TRBR returned another 6% whereas the S&P 500 index lost 0.7%.

2. Ladenburg Thalmann Financial Services Inc (LTS): Ladenburg Thalmann has been the worst performer among dozens of stocks we selected. LTS lost 10.1%, underperforming the SPY by 9.4 percentage points.

3. Career Education Corp (CECO): Career Education Corp has been satisfying our criteria over the past couple of months and we talked about it several times. In November and early December insiders were buying CECO shares at around $18. The stock closed at $21.57 on Friday. Steve Eisman’s Frontpoint Partners has been shorting for-profit education companies whereas Richard Blum is long CECO. Last week, CECO increased another 1.6%, beating the SPY by another 2.3 percentage points.

Overall, two out of three stocks we picked managed to beat the market. Unfortunately the average return of this portfolio was -0.8% vs. -0.7% for the S&P 500. This is the first time in 7 weeks our selections underperformed the SPY.  Here are three stocks insiders were buying like crazy last week:

1. A. Schulman Inc (SHLM): Barington’s James Mitarotonda has been buying more than 15,000 shares during the past few days. In his last transaction he paid $21.35, which was also the closing price for the stock on Friday. Schulman’s Chief Marketing Officer, Paul R. Boulier, purchased 1,200 shares at $21.08 a few days earlier.

2. Advanced Photonix Inc (API): Advanced Photonix made our list about a month ago. That time it returned 21% in one week, reaching $1.9 per share. There was another insider purchase last week. The insider paid around $1.9 per share but the stock closed the week at $1.74.

3. Winmark (WINA): Winmark made our insider purchase list two weeks ago, but it underperformed the market then. Since then the stock lost about 1% and we saw another stock purchase at $33.11.

Comments | Share

Barington Capital’s James Mitarotonda: Letter to Ameron International

Barington Capital’s James Mitarotonda sent a letter to Ameron International’s (AMN) board to oust CEO James Marlen.

“It appears to us that the primary achievement of Mr Marlen – who has earned over $66 million in total compensation during his 16+ years as CEO – has been creating wealth for himself and his family”, Mitarotonda wrote.

The letter said all three of Marlen’s sons hold senior positions at Ameron International and their employment should have been disclosed in a timely manner. Mitarotonda complained that Marlen’s earnings are 72% higher than the average CEO in his peer group.

Barington’s Mitarotonda blamed the CEO for running Ameron by “fear and intimidation”. He noted that the atmosphere at Ameron stifles the suggestion of new business initiatives and healthy discussion and debate about Mr. Marlen’s business proposals.

Barington Capital Group is a hedge fund, investing in small and mid-cap companies since 2000. Barington Capital returned 52% in 2009, and 29% in 2010.

Ameron – Barington Capital James Mitarotonda Letter Full

Comments | Share